The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 32 results:
Author Title Type [ Year(Asc)]
Filters: Author is Sardeli, Chrysanthi  [Clear All Filters]
2020
Sardeli, C., Zarogoulidis P., Romanidis K., Oikonomou P., Sapalidis K., Huang H., et al. (2020).  Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer.. Respir Med Case Rep. 31, 101258.
Zarogoulidis, P., Christakidis V., Petridis D., Sapalidis K., Kosmidis C., Vagionas A., et al. (2020).  Connection between PD-L1 expression and standardized uptake value in NSCLC: an early prognostic treatment combination.. Expert Rev Respir Med.
Sardeli, C., Zarogoulidis P., Kosmidis C., Amaniti A., Katsaounis A., Giannakidis D., et al. (2020).  Inhaled chemotherapy adverse effects: mechanisms and protection methods.. Lung Cancer Manag. 8(4), LMT19.
Zarogoulidis, P., Huang H., Yang M., Zhou J., Jiao Y., Wang Q., et al. (2020).  Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?. J Cancer. 11(6), 1606-1613.
Kosmidis, C., Sardeli C., Zarogoulidis P., Hohenforst-Schmidt W., Vagionas A., Ioannis-Katsios N., et al. (2020).  Producing the appropriate model and drug for intratumoural ablation.. Br J Cancer. 123(3), 335-336.
2019
Sapalidis, K., Zarogoulidis P., Petridis D., Kosmidis C., Fyntanidou B., Tsakiridis K., et al. (2019).  EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE.. J Cancer. 10(20), 4739-4746.
Sapalidis, K., Zarogoulidis P., Petridis D., Kosmidis C., Fyntanidou B., Tsakiridis K., et al. (2019).  EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE ®. Journal of Cancer. 10(20), 4739 - 4746.
Tsakiridis, I., Bousi V., Dagklis T., Sardeli C., Nikolopoulou V., & Papazisis G. (2019).  Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: a scoping review.. Arch Gynecol Obstet. 300(4), 849-859.
Sapalidis, K., Machairiotis N., Zarogoulidis P., Vasilakaki S., Sardeli C., Koimtzis G., et al. (2019).  Genes' Interactions: A Major Contributor to the Malignant Transformation of Endometriosis.. Int J Mol Sci. 20(8), 
Kosmidis, C., Sapalidis K., Zarogoulidis P., Sardeli C., Koulouris C., Giannakidis D., et al. (2019).  Inhaled Cisplatin for NSCLC: Facts and Results.. Int J Mol Sci. 20(8), 
Amaniti, A., Sardeli C., Fyntanidou V., Papakonstantinou P., Dalakakis I., Mylonas A., et al. (2019).  Pharmacologic and Non-Pharmacologic Interventions for HIV-Neuropathy Pain. A Systematic Review and a Meta-Analysis.. Medicina (Kaunas). 55(12), 
Sapalidis, K., Sardeli C., Pavlidis E., Koimtzis G., Koulouris C., Michalopoulos N., et al. (2019).  Scar tissue to lung cancer; pathways and treatment.. J Cancer. 10(4), 810-818.
Sapalidis, K., Kosmidis C., Funtanidou V., Katsaounis A., Barmpas A., Koimtzis G., et al. (2019).  Update on current pancreatic treatments: from molecular pathways to treatment.. J Cancer. 10(21), 5162-5172.
Sapalidis, K., Kosmidis C., Funtanidou V., Katsaounis A., Barmpas A., Koimtzis G., et al. (2019).  Update on current pancreatic treatments: from molecular pathways to treatment. Journal of Cancer. 10(21), 5162 - 5172.
2018
Sapalidis, K., Zarogoulidis P., Pavlidis E., Laskou S., Katsaounis A., Koulouris C., et al. (2018).  Aerosol Immunotherapy with or without Cisplatin for metastatic lung cancer non-small cell lung cancer disease: Study. A more efficient combination.. J Cancer. 9(11), 1973-1977.
Schizas, N., Lazopoulos A., Krimiotis D., Rallis T., Paliouras D., Gogakos A., et al. (2018).  Beware of hemopneumothorax following core needle breast biopsy.. Respir Med Case Rep. 25, 49-51.
Zarogoulidis, P., Sardeli C., Konstantinou F., & Sapalidis K. (2018).  Conventional Versus Therapeutic Stents for Airway Malignancies: Novel Local Therapies Underway.. EBioMedicine. 33, 10-11.
Perin, J., Zaric B., Đođić J. Eremić, Potić Z., Potić M., Sekeruš V., et al. (2018).  The cost of hospital treatment of advanced stage lung cancer patients in a developing South East European country.. J Cancer. 9(17), 3038-3045.
Zarogoulidis, P., Laskou S., Katsaounis A., Pavlidis E., Giannakidis D., Koulouris C., et al. (2018).  Esophagus lyomyoma diagnosed with convex endobronchial ultrasound (EBUS).. Respir Med Case Rep. 24, 95-97.
Sapalidis, K., Zarogoulidis P., Huang H., Bai C., Wen Y., Wang L., et al. (2018).  Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.. J Cancer. 9(6), 1121-1126.
Zarogoulidis, P., Papadopoulos V., Maragouli E., Papatsibas G., Sardeli C., Man Y-G., et al. (2018).  Nivolumab as first-line treatment in non-small cell lung cancer patients-key factors: tumor mutation burden and PD-L1 ≥50.. Transl Lung Cancer Res. 7(Suppl 1), S28-S30.
2017
Zarogoulidis, P., Chinelis P., Athanasiadou A., Tsiouda T., Trakada G., Kallianos A., et al. (2017).  Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases.. Respir Med Case Rep. 22, 101-105.
Gkotsos, G., Virgiliou C., Lagoudaki I., Sardeli C., Raikos N., Theodoridis G., et al. (2017).  The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer.. Metabolites. 7(1), 
Hohenforst-Schmidt, W., Zarogoulidis P., Steinheimer M., Benhassen N., Sardeli C., Stalikas N., et al. (2017).  Second-line afatinib administration in an elderly patient with squamous cell carcinoma.. Ther Clin Risk Manag. 13, 341-343.
2013
Papazisis, G., Garyfallos G., Sardeli C., & Kouvelas D. (2013).  Pregabalin abuse after past substance-seeking behavior.. Int J Clin Pharmacol Ther. 51(5), 441-2.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.